Zhang XW - Search Results

1

Expression of CD44 in pancreatic cancer and its significance.

Li XP, Zhang XW, Zheng LZ, Guo WJ. Li XP, et al. Among authors: zhang xw. Int J Clin Exp Pathol. 2015 Jun 1;8(6):6724-31. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26261555 Free PMC article.

2

UBTD1 induces cellular senescence through an UBTD1-Mdm2/p53 positive feedback loop.

Zhang XW, Wang XF, Ni SJ, Qin W, Zhao LQ, Hua RX, Lu YW, Li J, Dimri GP, Guo WJ. Zhang XW, et al. J Pathol. 2015 Mar;235(4):656-67. doi: 10.1002/path.4478. Epub 2015 Jan 7. J Pathol. 2015. PMID: 25382750

3

Oncogenic role of the chromobox protein CBX7 in gastric cancer.

Zhang XW, Zhang L, Qin W, Yao XH, Zheng LZ, Liu X, Li J, Guo WJ. Zhang XW, et al. Among authors: zhang l. J Exp Clin Cancer Res. 2010 Aug 19;29(1):114. doi: 10.1186/1756-9966-29-114. J Exp Clin Cancer Res. 2010. PMID: 20723236 Free PMC article.

4

Mel-18 negatively regulates stem cell-like properties through downregulation of miR-21 in gastric cancer.

Wang XF, Zhang XW, Hua RX, Du YQ, Huang MZ, Liu Y, Cheng YF, Guo WJ. Wang XF, et al. Among authors: zhang xw. Oncotarget. 2016 Sep 27;7(39):63352-63361. doi: 10.18632/oncotarget.11221. Oncotarget. 2016. PMID: 27542229 Free PMC article.

5

CBX7 regulates stem cell-like properties of gastric cancer cells via p16 and AKT-NF-κB-miR-21 pathways.

Ni SJ, Zhao LQ, Wang XF, Wu ZH, Hua RX, Wan CH, Zhang JY, Zhang XW, Huang MZ, Gan L, Sun HL, Dimri GP, Guo WJ. Ni SJ, et al. Among authors: zhang jy, zhang xw. J Hematol Oncol. 2018 Feb 8;11(1):17. doi: 10.1186/s13045-018-0562-z. J Hematol Oncol. 2018. PMID: 29422082 Free PMC article.

6

BMI1 and Mel-18 oppositely regulate carcinogenesis and progression of gastric cancer.

Zhang XW, Sheng YP, Li Q, Qin W, Lu YW, Cheng YF, Liu BY, Zhang FC, Li J, Dimri GP, Guo WJ. Zhang XW, et al. Among authors: zhang fc. Mol Cancer. 2010 Feb 21;9:40. doi: 10.1186/1476-4598-9-40. Mol Cancer. 2010. PMID: 20170541 Free PMC article.

7

Cetuximab enhances the activities of irinotecan on gastric cancer cell lines through downregulating the EGFR pathway upregulated by irinotecan.

Liu X, Guo WJ, Zhang XW, Cai X, Tian S, Li J. Liu X, et al. Among authors: zhang xw. Cancer Chemother Pharmacol. 2011 Oct;68(4):871-8. doi: 10.1007/s00280-011-1559-2. Epub 2011 Feb 1. Cancer Chemother Pharmacol. 2011. PMID: 21286718

8

COX-2-765G>C polymorphism increases the risk of cancer: a meta-analysis.

Wang XF, Huang MZ, Zhang XW, Hua RX, Guo WJ. Wang XF, et al. Among authors: zhang xw. PLoS One. 2013 Sep 4;8(9):e73213. doi: 10.1371/journal.pone.0073213. eCollection 2013. PLoS One. 2013. PMID: 24023834 Free PMC article.

9

XELOX doublet regimen versus EOX triplet regimen as first-line treatment for advanced gastric cancer: An open-labeled, multicenter, randomized, prospective phase III trial (EXELOX).

Zhu XD, Huang MZ, Wang YS, Feng WJ, Chen ZY, He YF, Zhang XW, Liu X, Wang CC, Zhang W, Ying JE, Wu J, Yang L, Qin YR, Luo JF, Zhao XY, Li WH, Zhang Z, Qiu LX, Geng QR, Zou JL, Zhang JY, Zheng H, Song XF, Wu SS, Zhang CY, Gong Z, Liu QQ, Wang XF, Xu Q, Wang Q, Ji JM, Zhao J, Guo WJ. Zhu XD, et al. Among authors: zhang cy, zhang xw, zhang w, zhang jy, zhang z. Cancer Commun (Lond). 2022 Apr;42(4):314-326. doi: 10.1002/cac2.12278. Epub 2022 Feb 25. Cancer Commun (Lond). 2022. PMID: 35212487 Free PMC article. Clinical Trial.

10

FAK alleviates radiation-induced rectal injury by decreasing apoptosis.

Li JJ, Tu WZ, Chen XM, Ying HY, Chen Y, Ge YL, Wang J, Xu Y, Chen TF, Zhang XW, Ye JJ, Liu Y. Li JJ, et al. Among authors: zhang xw. Toxicol Appl Pharmacol. 2018 Dec 1;360:131-140. doi: 10.1016/j.taap.2018.10.007. Epub 2018 Oct 4. Toxicol Appl Pharmacol. 2018. PMID: 30292832

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,273 results

Search Page